Detalles de la búsqueda
1.
Preferred Conformation-Guided Discovery of Potent and Orally Active HIF Prolyl Hydroxylase 2 Inhibitors for the Treatment of Anemia.
J Med Chem
; 66(13): 8545-8563, 2023 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37367818
2.
Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia.
Eur J Med Chem
; 238: 114479, 2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675755
3.
Corrigendum to "Tetrahydropyridin-4-ylpicolinoylglycines as novel and orally active prolyl hydroxylase 2 (PHD2) inhibitors for the treatment of renal anemia" [Eur. J. Med. Chem. 238 (2022) 114479].
Eur J Med Chem
; 259: 115692, 2023 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550158
Resultados
1 -
3
de 3
1
Próxima >
>>